Also, it has been observed that high-expressed MNX1-AS1 has been found to be related to poor differentiation, tumor size, advanced clinical stage, distant metastasis, and lymph node metastasis of LUAD patients. Here, MNX1 is linked to metastatic malignant neoplasm in the lymph nodes.